Insulin glargine and lixisenatide and Panatuss DXP
Determining the interaction of Insulin glargine and lixisenatide and Panatuss DXP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: dexbrompheniramine / dextromethorphan / phenylephrine
Brand name: Alahist CF, G-P-Tuss DXP, Panatuss DXP, Supress A Pediatric, Alahist DM, Bionatuss, Supress A, Tussall, Tussall-ER, Dexall, Y-Cof DM, Panatuss Pediatric DXP
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Panatuss PED
- Insulin glargine and lixisenatide-Panatuss PED Drops
- Insulin glargine and lixisenatide-Pancof HC
- Insulin glargine and lixisenatide-Pancof XP
- Insulin glargine and lixisenatide-Pancreatin
- Insulin glargine and lixisenatide-Pancreatin 4X
- Panatuss DXP-Insulin glargine and lixisenatide Subcutaneous
- Panatuss DXP-Insulin glargine, recombinant Subcutaneous
- Panatuss DXP-Insulin glulisine
- Panatuss DXP-Insulin Glulisine (Cartridges and Pens)
- Panatuss DXP-Insulin Glulisine (Vials)
- Panatuss DXP-Insulin glulisine Subcutaneous